{"id":"W4416658298","doi":"10.5256/f1000research.153058.r196057","title":"Referee report. For: The identification of high-performing antibodies for Charged multivesicular body protein 2b for use in Western Blot, immunoprecipitation and immunofluorescence [version 1; peer review: 2 approved]","year":2023,"lang":"en","type":"article","venue":"Faculty of 1000 Research Ltd","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Genentech; Government of Canada; Ontario Genomics Institute; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; Mitacs; Ontario Genomics; Genome Canada; Bayer; Motor Neurone Disease Association; Pfizer; Bristol-Myers Squibb","keywords":"Immunoprecipitation; Immunofluorescence; Identification (biology); Antibody; Indirect immunofluorescence; Blot","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"other","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"medium","status":"direct model label, unvalidated"}],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008362018,0.0001611607,0.0004674508,0.000327164,0.0003164666,0.00004013779,0.0002725963,0.0001048085,0.000006487966],"category_scores_gemma":[0.008119038,0.0001101717,0.0001647913,0.0004449005,0.0003334612,0.0002459443,0.000166987,0.0002835501,0.000005671321],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000768887,"about_ca_system_score_gemma":0.0001372943,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001270987,"about_ca_topic_score_gemma":0.00008500339,"domain_scores_codex":[0.9967219,0.0001589885,0.0008302694,0.0004258787,0.001386713,0.0004762376],"domain_scores_gemma":[0.9933779,0.001340325,0.0002869922,0.0004626463,0.004463483,0.00006860815],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003463111,0.0002078588,0.01133194,0.009815285,0.0001942616,0.000008769764,0.0009694399,0.000006398715,0.9443138,0.0002984825,0.01934107,0.01004964],"study_design_scores_gemma":[0.004142741,0.001441249,0.3525758,0.005970914,0.0001156324,0.00002157054,0.001390618,0.007567327,0.4793893,0.0003976477,0.1466936,0.0002936649],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9657763,0.002329492,0.0006881749,0.02299921,0.00005013405,0.00730853,0.0008164449,0.00002115204,0.00001056511],"genre_scores_gemma":[0.8596008,0.009142797,0.005089032,0.00004298976,0.0001541666,0.003077679,0.006950004,0.00007213029,0.1158704],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4649245,"threshold_uncertainty_score":0.9719834,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08403497584241056,"score_gpt":0.408225091497139,"score_spread":0.3241901156547285,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}